Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 12/2014

01.12.2014 | Original Article

In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model

verfasst von: Cajetan Lang, Sebastian Lehner, Andrei Todica, Guido Boening, Mathias Zacherl, Wolfgang-Michael Franz, Bernd Joachim Krause, Peter Bartenstein, Marcus Hacker, Robert David

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Various strategies have been applied to increase the engraftment of an intramyocardial cell transplant (Tx) to treat ischemic myocardium. Thereby, co-transplanted fibroblasts (FB) improve the long-term survival of stem cell derivatives (SCD) in a murine model of myocardial infarction. For therapeutic use, the time frame in which FB exert putative supportive effects needs to be identified. Therefore, we tracked the biodistribution and retention of SCD and FB in vivo using highly sensitive positron emission tomography (PET) imaging.

Methods

Murine [18 F]-fluorodeoxyglucose (FDG) labeled SCD and FB were transplanted after left anterior descending artery (LAD) ligation into the border zone of the ischemic area in female C57BL/6 mice. Cardiac retention and biodistribution during the initial 2 h after injection were measured via PET imaging.

Results

Massive initial cell loss occurred independently of the cell type. Thereby, FB were retained slightly, yet significantly better than SCD until 60 min post-injection (7.5 ± 1.7 vs. 5.2 ± 0.7 % ID at 25 min and 7.0 ± 1.5 vs. 4.8 ± 0.8 % ID at 60 min). Thereafter, a fraction of ∼5 % that withstood the massive initial washout remained at the site of injection independently of the applied cell type (120 min, SCD vs. FB P = 0.64). Most of the lost cells were detected in the lungs (∼30 % ID).

Conclusions

We were able to quantitatively define the retention and biodistribution of different cell types via PET imaging in a mouse model after intramyocardial Tx. The utmost accuracy was achieved through this cell- and organ-specific approach by correcting PET data for cellular FDG efflux. Thereby, we observed a massive initial cell loss of ∼95 %, causing low rates of long-term engraftment for both SCD and FB. We conclude that FB are not privileged compared to SCD regarding their acute retention kinetics, and therefore exert their beneficial effects at a later time point.
Literatur
1.
Zurück zum Zitat Bernhardt AM, Rahmel A, Reichenspurner H. The unsolved problem of organ allocation in times of organ shortage: the German solution? J Heart Lung Transplant: Off Publ Int Soc Heart Transplant. 2013;32(11):1049–51. doi:10.1016/j.healun.2013.08.012.CrossRef Bernhardt AM, Rahmel A, Reichenspurner H. The unsolved problem of organ allocation in times of organ shortage: the German solution? J Heart Lung Transplant: Off Publ Int Soc Heart Transplant. 2013;32(11):1049–51. doi:10.​1016/​j.​healun.​2013.​08.​012.CrossRef
3.
Zurück zum Zitat Donndorf P, Kundt G, Kaminski A, Yerebakan C, Liebold A, Steinhoff G, et al. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. J Thorac Cardiovasc Surg. 2011;142(4):911–20. doi:10.1016/j.jtcvs.2010.12.013.PubMedCrossRef Donndorf P, Kundt G, Kaminski A, Yerebakan C, Liebold A, Steinhoff G, et al. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. J Thorac Cardiovasc Surg. 2011;142(4):911–20. doi:10.​1016/​j.​jtcvs.​2010.​12.​013.PubMedCrossRef
4.
Zurück zum Zitat Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, et al. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail. 2012;14(1):91–105. doi:10.1093/eurjhf/hfr148.PubMedCrossRef Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, et al. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail. 2012;14(1):91–105. doi:10.​1093/​eurjhf/​hfr148.PubMedCrossRef
6.
Zurück zum Zitat Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008;117(9):1189–200. doi:10.1161/CIRCULATIONAHA.107.734103.PubMedCrossRef Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008;117(9):1189–200. doi:10.​1161/​CIRCULATIONAHA.​107.​734103.PubMedCrossRef
7.
Zurück zum Zitat Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006;203(10):2315–27. doi:10.1084/jem.20061469.PubMedCentralPubMedCrossRef Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006;203(10):2315–27. doi:10.​1084/​jem.​20061469.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000;119(6):1169–75.PubMedCrossRef Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000;119(6):1169–75.PubMedCrossRef
11.
Zurück zum Zitat Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res. 2002;91(10):888–98.PubMedCrossRef Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res. 2002;91(10):888–98.PubMedCrossRef
13.
14.
Zurück zum Zitat Bonios M, Terrovitis J, Chang CY, Engles JM, Higuchi T, Lautamaki R, et al. Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. J Nucl Cardiol: Off Publ Am Soc Nucl Cardiol. 2011;18(3):443–50. doi:10.1007/s12350-011-9369-9.CrossRef Bonios M, Terrovitis J, Chang CY, Engles JM, Higuchi T, Lautamaki R, et al. Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. J Nucl Cardiol: Off Publ Am Soc Nucl Cardiol. 2011;18(3):443–50. doi:10.​1007/​s12350-011-9369-9.CrossRef
15.
Zurück zum Zitat Lautamaki R, Terrovitis J, Bonios M, Yu J, Tsui BM, Abraham MR, et al. Perfusion defect size predicts engraftment but not early retention of intra-myocardially injected cardiosphere-derived cells after acute myocardial infarction. Basic Res Cardiol. 2011;106(6):1379–86. doi:10.1007/s00395-011-0197-5.PubMedCentralPubMedCrossRef Lautamaki R, Terrovitis J, Bonios M, Yu J, Tsui BM, Abraham MR, et al. Perfusion defect size predicts engraftment but not early retention of intra-myocardially injected cardiosphere-derived cells after acute myocardial infarction. Basic Res Cardiol. 2011;106(6):1379–86. doi:10.​1007/​s00395-011-0197-5.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Lang C, Lehner S, Todica A, Boening G, Franz WM, Bartenstein P, et al. Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse model. Eur J Nucl Med Mol Imaging. 2013;40(11):1730–8. doi:10.1007/s00259-013-2480-1.PubMedCrossRef Lang C, Lehner S, Todica A, Boening G, Franz WM, Bartenstein P, et al. Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse model. Eur J Nucl Med Mol Imaging. 2013;40(11):1730–8. doi:10.​1007/​s00259-013-2480-1.PubMedCrossRef
17.
Zurück zum Zitat Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J Off Publ Fed Am Soc Exp Biol. 2000;14(15):2540–8. doi:10.1096/fj.00-0002com. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J Off Publ Fed Am Soc Exp Biol. 2000;14(15):2540–8. doi:10.​1096/​fj.​00-0002com.
18.
Zurück zum Zitat David R, Brenner C, Stieber J, Schwarz F, Brunner S, Vollmer M, et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol. 2008;10(3):338–45. doi:10.1038/ncb1696.PubMedCrossRef David R, Brenner C, Stieber J, Schwarz F, Brunner S, Vollmer M, et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol. 2008;10(3):338–45. doi:10.​1038/​ncb1696.PubMedCrossRef
20.
Zurück zum Zitat Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20(7):956–8. doi:10.1096/fj.05-4763fje. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20(7):956–8. doi:10.​1096/​fj.​05-4763fje.
21.
Zurück zum Zitat van Laake LW, Passier R, Monshouwer-Kloots J, Nederhoff MG, Ward-van Oostwaard D, Field LJ, et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc. 2007;2(10):2551–67. doi:10.1038/nprot.2007.371.PubMedCrossRef van Laake LW, Passier R, Monshouwer-Kloots J, Nederhoff MG, Ward-van Oostwaard D, Field LJ, et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc. 2007;2(10):2551–67. doi:10.​1038/​nprot.​2007.​371.PubMedCrossRef
22.
25.
27.
Zurück zum Zitat Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29(15):1807–18. doi:10.1093/eurheartj/ehn220.PubMedCrossRef Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29(15):1807–18. doi:10.​1093/​eurheartj/​ehn220.PubMedCrossRef
28.
Zurück zum Zitat Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F, et al. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 2008;103(11):1327–34. doi:10.1161/CIRCRESAHA.108.180463.PubMedCrossRef Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F, et al. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 2008;103(11):1327–34. doi:10.​1161/​CIRCRESAHA.​108.​180463.PubMedCrossRef
30.
Zurück zum Zitat Muller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol. 2006;41(5):876–84. doi:10.1016/j.yjmcc.2006.07.023.PubMedCrossRef Muller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol. 2006;41(5):876–84. doi:10.​1016/​j.​yjmcc.​2006.​07.​023.PubMedCrossRef
31.
Zurück zum Zitat Sakai T, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg. 1999;118(4):715–24.PubMedCrossRef Sakai T, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg. 1999;118(4):715–24.PubMedCrossRef
32.
Zurück zum Zitat Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 2000;9(3):359–68.PubMed Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 2000;9(3):359–68.PubMed
33.
Zurück zum Zitat Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation. 2002;105(20):2435–41.PubMedCrossRef Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation. 2002;105(20):2435–41.PubMedCrossRef
34.
Zurück zum Zitat Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol. 2007;293(3):H1883–91. doi:10.1152/ajpheart.00514.2007.PubMedCrossRef Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol. 2007;293(3):H1883–91. doi:10.​1152/​ajpheart.​00514.​2007.PubMedCrossRef
36.
Zurück zum Zitat Kobayashi H, Shimizu T, Yamato M, Tono K, Masuda H, Asahara T, et al. Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs: Off J Jpn Soc Artif Organs. 2008;11(3):141–7. doi:10.1007/s10047-008-0421-8.CrossRef Kobayashi H, Shimizu T, Yamato M, Tono K, Masuda H, Asahara T, et al. Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs: Off J Jpn Soc Artif Organs. 2008;11(3):141–7. doi:10.​1007/​s10047-008-0421-8.CrossRef
37.
Zurück zum Zitat Mitchell AJ, Sabondjian E, Blackwood KJ, Sykes J, Deans L, Feng Q, et al. Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction. Int J Cardiovasc Imaging. 2013;29(2):497–504. doi:10.1007/s10554-012-0086-5.PubMedCentralPubMedCrossRef Mitchell AJ, Sabondjian E, Blackwood KJ, Sykes J, Deans L, Feng Q, et al. Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction. Int J Cardiovasc Imaging. 2013;29(2):497–504. doi:10.​1007/​s10554-012-0086-5.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS. Tissue distribution of 18 F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med: Off Publ Soc Nucl Med. 2006;47(8):1295–301. Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS. Tissue distribution of 18 F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med: Off Publ Soc Nucl Med. 2006;47(8):1295–301.
39.
Zurück zum Zitat Schots R, De Keulenaer G, Schoors D, Caveliers V, Dujardin M, Verheye S, et al. Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure. Exp Hematol. 2007;35(12):1884–90. doi:10.1016/j.exphem.2007.07.012.PubMedCrossRef Schots R, De Keulenaer G, Schoors D, Caveliers V, Dujardin M, Verheye S, et al. Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure. Exp Hematol. 2007;35(12):1884–90. doi:10.​1016/​j.​exphem.​2007.​07.​012.PubMedCrossRef
40.
Zurück zum Zitat Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169(1):12–20.PubMedCrossRef Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169(1):12–20.PubMedCrossRef
41.
Zurück zum Zitat Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis (N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A. 2002;99(5):3030–5. doi:10.1073/pnas.052709599.PubMedCentralPubMedCrossRef Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis (N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A. 2002;99(5):3030–5. doi:10.​1073/​pnas.​052709599.PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Botti C, Negri DR, Seregni E, Ramakrishna V, Arienti F, Maffioli L, et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med. 1997;24(5):497–504.PubMed Botti C, Negri DR, Seregni E, Ramakrishna V, Arienti F, Maffioli L, et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med. 1997;24(5):497–504.PubMed
43.
Zurück zum Zitat Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18 F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med: Off Publ, Soc Nucl Med. 1978;19(10):1154–61. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of oradiopharmaceutical design: some factors responsible for the biodistribution of [18 F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med: Off Publ, Soc Nucl Med. 1978;19(10):1154–61.
44.
Zurück zum Zitat Caraco C, Aloj L, Chen LY, Chou JY, Eckelman WC. Cellular release of [F-18]2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system. J Biol Chem. 2000;275(24):18489–94. doi:10.1074/jbc.M908096199.PubMedCrossRef Caraco C, Aloj L, Chen LY, Chou JY, Eckelman WC. Cellular release of [F-18]2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system. J Biol Chem. 2000;275(24):18489–94. doi:10.​1074/​jbc.​M908096199.PubMedCrossRef
45.
Zurück zum Zitat Stojanov K, de Vries EF, Hoekstra D, van Waarde A, Dierckx RA, Zuhorn IS. [18 F] FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin. Mol Imaging. 2012;11(1):1–12.PubMed Stojanov K, de Vries EF, Hoekstra D, van Waarde A, Dierckx RA, Zuhorn IS. [18 F] FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin. Mol Imaging. 2012;11(1):1–12.PubMed
47.
Zurück zum Zitat Wolfs E, Struys T, Notelaers T, Roberts SJ, Sohni A, Bormans G, et al. 18 F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med: Off Publ, Soc Nucl Med. 2013;54(3):447–54. doi:10.2967/jnumed.112.108316.CrossRef Wolfs E, Struys T, Notelaers T, Roberts SJ, Sohni A, Bormans G, et al. 18 F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med: Off Publ, Soc Nucl Med. 2013;54(3):447–54. doi:10.​2967/​jnumed.​112.​108316.CrossRef
Metadaten
Titel
In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model
verfasst von
Cajetan Lang
Sebastian Lehner
Andrei Todica
Guido Boening
Mathias Zacherl
Wolfgang-Michael Franz
Bernd Joachim Krause
Peter Bartenstein
Marcus Hacker
Robert David
Publikationsdatum
01.12.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2014
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-014-2858-8

Weitere Artikel der Ausgabe 12/2014

European Journal of Nuclear Medicine and Molecular Imaging 12/2014 Zur Ausgabe